In man, mechanisms for potassium excretion are complex and highly developed, while potassium conservation is potentially inadequate. Potassium balance is regulated by alterations in excretion in the distal renal tubule, where mineralocorticoid hormones and N a-K ATPase are the major regulating factors. The distribution of potassium across cell membranes is influenced by changes in acid-base stattts, by pancreatic hormones and by the autonomic nervous system. Potassium stimulates insulin and aldosterone secretion and increases Na-K ATPase in the distal nephron, so promoting its own redistribution or excretion. Emergency management of hyperkalaemia is best effected by promoting cell-entry of potassium, rather than renal excretion. The speed of replacement of deficits is always limited by the small extracellular potassium pool.
INTRODUCTION
Potassium is the major intracellular cation and determinant of membrane polarization; consequently its plasma concentration must be precisely regulated, irrespective of total body content. This is achieved both by change in distribution across cell membranes and by modification of renal excretion. Because intake, absorption and proximal renal reabsorption do not show regulatory variation, total body potassium balance is controlled by appropriate changes in excretion in the distal portion of the nephron.
Potassium homeostasis can be disturbed by renal impairment, disturbances of acid-base balance, excessive tissue breakdown, abnormal routes of loss, aberrations of sodium balance and mineralocorticoid abnormalities. Potassium overload is opposed by several factors which are directly responsive to an increase in its blood level. A rise in plasma potassium can directly stimulate aldosterone production, insulin secretion and sodium-potassium ATPase in the renal medulla; each of these factors either promotes the movement of potassium into cells, or its excretion in urine.
In man, mechanisms which prevent potassium overload are much more highly developed than those which prevent depletion, perhaps because feral man ingested a diet high in potassium and low in sodium. This background equips us poorly for the present day high-sodium, low-potassium environment (Meneely and Battarbee 1976) .
This review will summarize recent advances in our understanding of the multiple mechanisms which regulate potassium balance. The consequences of potassium imbalance will not be considered fully, but the pathologic or therapeutic significance of the major potassium regulating mechanisms will be shown by clinical examples. The review is necessarily incomplete; further information is available from other sources (Schultze 1973 , Lowenstein 1973 , Vaughan and Lunn 1973 , Brenner and Berliner 1973 , Stockigt 1977 , Kunau and Stein 1977 .
HANDLING OF POTASSIUM LOADS
The multiple mechanisms which oppose potassium overload are summarized in Figure l. In the small bowel lumen, the potassium content of ingested food rapidly approaches the plasma concentration (Phillips and Summerskill 1967) . Absorption from small bowel is passive, leading to movement of ingested potassium into an extracellular space which contains less than 2% of total body potassium. Because this pool is no larger than daily intake, potent defences are essential to prevent lethal hyperkalaemia after oral or parenteral potassium loads. \Vhen a potassium load is given parenterally, the speed of administration is more critical than the amount, because the small extracellular pool can e~'iily be overloaded.
The ability to survive acute potassium loads is described ~" potassium tolerance, while adaptation describes the increased tolerance which is induced by prior high potassium INGESTION Sudden changes of pot~'isium intake are uncommon in man, hut hypokalaemic muscle paralysis has been reported in ::\ew Guineans after migration from ,L region of high to low potassiulll intake (Duggin and Price 1 H7.!). Hypokalaemic paralysis occurred within the first two months after change from a highland diet low in sodium and high in potassiulll, to a coastal diet in which the sodium: potassium ratio W,L'i reversed. This suggests that mechanisms which alter potassium excretion may be slow to change.
There is now good evidence that pancreatic hormones play an important part in acute redistribution of potassium loads by insulininduced entry of glucose and potassiulll into cells (Santeusanio et al. 1 H7:)). Acute potassium tolerance studies showed poor sun'ival of pancreatectomized dogs following large acute infusions of pot~ssium, but tolerance was restored by infusion of insulin and glucagon, suggesting that disposal was dependent on pancreatic hormone,.; (Hiatt, Yamakawa and Davidson 1974) . It is notable that potassium stimulates release of both insulin and glucagon (Santeusanio et al. 1973) , so as to promote K + removal from extracellular fluid without major change in blood sugar ( Figure 2) . A change in plasma potassium, well within the physiologic range, stimulates insulin secretion in normal subjects, suggesting an important role for this mechanism in normal physiology (Dluhy, Axelrod and Williams In72) . While it is usually presumed that the fall in potassium is the result of glucose entry into cells, the studies of Zierler ()!166) suggest that potassium influx (or diminished efflux) may be a direct result of insulin action. Paradoxical glucoseinduced hyperkalaemia has been reported in diabetic patients, who lack an appropriate glucose-induced insulin response (Goldfarb et al. In76), while potentially dangerous hypokalaemia may occur during insulin-induced hypoglycaemia (Strakosch, Stiel and Gyory ] 976). The autonomic nervous svstem is also important in potassium distribution across cell melllbranes. Adrenaline has a biphasic effect on plasllla potassium, with an initial alpha-adrenergic increase, followed lJy a more sustained beta-mediated hypokalaemic effect. Concurrent adrenaline infusion during potassium loading has been shown to have a protective effect against otherwise lethal hyperkalaemia (Lockwoocl and LUIll J97.!). This effect, which was indCjwndent of pancreatic insulin secretion, could he blocked hv beta., and non-selective beta hlockade, hut· not G y beta l hlockade.
Prevention of attacks of hyperkalaemic periodic paralysis has recently been reported by use of the beta 2 agonist, Salbutamol (Wang and Clausen 1976) , further supporting the existence of an autonomic potassium-lowering mechanism. Isoproterenol has been shown to lower plasma potassium in dogs by an effect independent of pancreatic hormones (Pettit and Vick 1974) , while alpha adrenergic activity increased potassium. The ganglion blocker, Trimetaphan has been shown to lower serum potassium during intraoperative hypotension (Fahmy 1976) .
THE KIDNEY AND POTASSIUM
The kidney is the dominant organ in maintaining normal potassium balance. I ts very large excretory reserve is demonstrated by the ability of remaining nephrons to excrete potassium in excess of the amount filtered in chronic renal insufficiency. Different parts of the nephron handle potassium in different ways, with major regulatory function confined entirely to the distal convoluted tubule and collecting ducts ( Figure 3 ). In the proximal convoluted tubule 85-90% of filtered potassium is reabsorbed and some further reabsorption occurs in the thick section of Henle's loop. Proximal reabsorption does not show any regulatory variation in different states of potassium balance, so that urinary excretion may vary lOO-fold with fairly constant amounts of potassium entering the early distal tubule. It is in the distal tubule that mineralocorticoid hormones have their major action, but potassium excretion is also influenced by the state of acid-base balance, by the activity of sodium potassium ATPase in the collecting ducts and by the rate of flow along the distal convoluted tubule-a factor markedly dependent on proximal tubular sodium reabsorption.
85-90%
These four major determinants of potassium excretion will be briefly summarized:
(a) Mineralocorticoid Hormones. Aldosterone, the major mineralocorticoid in man, is responsive to sodium restriction, but a rise in plasma potassium is also a potent and specific stimulus to aldosterone production, by an action quite independent of the renin-angiotensin system. A rise in plasma potassium of less than o ·5 mmoljl will increase aldosterone secretion, while prior high potassium intake magnifies the aldosterone response to acute loads .
The importance of adrenal corticosteroids in potassium homeostasis is well-known, as in the hyperkalaemia of Addisonian crisis. However, potassium excess is a late feature of Addison's disease and is uncommon until renal function and acid-base balance are disturbed (Black 1972). I t is clear that factors other than mineralocorticoid hOlmones are involved in potassium excretion, because Addisonian subjects maintained on fixed mineralocorticoid replacement with 0·2 mg of 9 cx-fluorohydrocortisone daily, were able to increase urinary potassium from 40 to 170 mmoljday when intake was increased from 60 to 200 mmoljday (Miller et al. 1975) .
It has been widely stated that sodium and potassium ions exchange in the distal convoluted tubule, but this view is probably false. Micropuncture studies have shown that distal tubular reabsorption of sodium is always much greater than combined secretion of potassium and hydrogen (Malnic, Klose and Giebisch 1966) . Furthermore, sodium reabsorption occurs predominantly in the early distal tubule, while maximum potassium secretion occurs in the late distal tubule.
The action of mineralocorticoid hormones to promote potassium excretion, is summarized in Figure 4 . The tubular lumen becomes progressively more electronegative in the late distal tubule and this favours potassium movement into the lumen. Aldosterone appears to increase potassium entry from peritubular fluid into the distal convoluted tubule cells by an active mechanism, in addition to its effect to enhance luminal permeability to potassium (Wiederholt, Agulian and Khuri 1974) .
(b) Sodium-potassium ATPase. Silva et al. (1975) have reported that an increase in the activity of this enzyme enables the isolated, perfused kidneys from potassium-loaded rats to excrete up to three times the amount of potassium filtered at the glomerulus. The activity of this enzyme in the renal papilla was directly induced by potassium, while gluco-and mineralocorticoid, and prior sodium restriction were inactive at this site. This mechanism appears to be most important in producing the marked increase in potassium excretion per nephron in renal insufficiency. (c) Distal tubular flow. Because the potassium gradient across the wall of the distal renal tubule is independent of distal tubular flow rate, a high flow rate will result in more excretion than a low flow rate (Khuri et al. 1975) . Distal urine flow diminishes in states of sodium deficiency, or volume depletion, where proximal tubular sodium reabsorption is more complete. This is the probable explanation for the diminished mineralocorticoid effect on potassium excretion during severe sodium restriction. Hence, the kaliuretic effect of fixed excess of mineralocorticoid, is increased during liberal sodium intake and diminished by sodium restriction. Consequently, sodium restriction is critical in achieving potassium repletion in both primary and secondary mineralocorticoid excess.
(d) Acid-base balance. A hydrogen ion deficit will increase intracellular potassium in many cells, including the distal renal tubule, and this is the most likely explanation for the short-term inverse relationship between urinary potassium and hydrogen ion excretion. However, the long-term renal responses to acid-base disturbances are more complex and depend on distal sodium and anion loads rather than on a simple inverse relationship between H + and K +. Sustained respiratory alkalosis produces a transient increase in potassium excretion, but severe chronic urinary potassium loss does not occur. However, chronic metabolic alkalosis results in severe, progressive urinary potassium depletion. These complex changes have been well reviewed by Gennari and Cohen (1975) .
POTASSIUM CONSERVATION
In contrast to the multiple excretory mechanisms outlined above, potassium conservation is not highly developed in man. Sevele potassium lack is rare in natural diets, but contemporary preparation of food by prolonged boiling markedly reduces potassium content and creates an environmental stress, which, together with potent modern pharmacology, creates a serious danger of deficiency. Investigation of the effect of pure potassium lack is difficult, because food-deprivation results in catabolic release of intracellular potassium. During severe isocaloric potassium restriction urine potassium falls to levels lower than the plasma concentration-evidence for net renal reabsorption. However, bowel loss continues, and a progressive deficit of up to 400 mmol may develop over 20 days, associated with definite hypokalaemia (Squires and Huth 1959) . This progressive loss of about 15% of total body potassium is in marked contrast to the very efficient conservation possible for sodium. In subjects who are stressed or ill, urine potassium conservation is probably even less effective than in normal subjects.
ASSESSMENT OF POTASSIUM STATUS
Because electrocardiographic monitoring reflects minute-to-minute changes in transmembrane potassium gradient (Surawicz 1967) , it is irreplaceable where rapid fluctuations in potassium are intended or anticipated. This assessment is usually combined with biochemical measurement, to define abnormalities and to monitor therapy. Measurement of serum or plasma potassium is the best biochemical index of potassium status, despite the fact that this measurement represents less than 2% of total body content. Extracellular potassium concentration may at times deviate acutely in a direction opposite to the abnormality of total body content, as in diabetic ketoacidosis. In acute fluctuations of potassium distribution, such as occur with disturbances of acid-base balance, it is the plasma concentration which is the most critical value, irrespective of total-body balance. An acute disturbance of plasma level will disturb transmembrane potential more than a chronic imbalance, where intra-and extracellular, concentrations tend to change in the same direction (Seldin, Carter and Rector 1971) . Because acute manipUlation of plasma potassium is potentially lethal, it is critical to be aware of artifacts which give spurious potassium measurements (Table 2) and to avoid acute treatment on the basis of a single, unexpected laboratory result.
Measurement of total body potassium is more complex, requiring either a whole-body counter (4°K) or administration of isotope (12K). Such measurements may confuse rather than improve assessment, because of illness-related changes in body composition which produce secondary loss of potassium. The potassium content of adipose tissue is low, so that a disproportionate decrease in muscle mass will give low total potassium without a true deficiency (de Deuxchaisnes and Mach 1974) . This measurement is most useful in overall assessment of body composition, or in serial studies of the same subject, but has very limited routine application. Results must always be interpreted cautiously in chronically ill patients because replacement of a non-deficiency creates the danger of potassium overload.
Measurement of red cell, leukocyte, or muscle potassium concentrations (Patrick et al. 1972) can suffer from artifacts of sample preparation and have not found wide use. Measurement of urinary potassium (without supplements or diuretics) can be used to establish urinary loss as the cause of hypokalaemia (Kaplan 1967) , but considerable faecal excretion makes this measurement less useful than urinary sodium measurement. HYPOKALAEMIA A low plasma potassium should be suspected in any patient who has been receiving diuretics for cardiac failure, cirrhosis with ascites, or nephrotic syndrome. In each of these situations, a low effective plasma volume is the rule, leading to secondary hyperaldosteronism and chronic potassium loss, which may not be adequately covered by routine supplements. Diuretic treatment of uncomplicated essential hypertension, on the other hand, is usually not associated with potassium deficiency (Wilkinson et al. 1975) . Severe, unsuspected hypokalaemia may follow diuretic or purgative abuse, or occult vomiting in patients who are otherwise physically well. Potassium depletion is seen at its most severe in patients with chronic, high gastrointestinal obstruction, where Gastrointestinal the major potassium loss is urinary, because of severe uncompensated metabolic alkalosis. In most conditions, the potassium aberration is secondary to another process, but in the hypoand hyperkalaemic forms of periodic paralysis, acute shift of potassium across cell membranes appears to be the primary abnormality (Zierler 1973) . The common causes of hypokalaemia are outlined in Table 1. Hypokalaemia, whether found by measurement in a suspect patient, or because of unexpected arrhythmia, cardiographic change or delayed return of spontaneous respiration after anaesthesia, requires acute and chronic management. Intravenous administration of potassium is the most direct way of repairing an acute deficit, but because of the small extracellular pool, intravenous administration must net'er exceed a critical rate of about 20 mmol per hour, no matter how severe the deficit. Even this rate may be excessive in situations where there is illlpaired potassium entry into cells, such as in respiratory acidosis (Scrilmer, Fremont-Smith and Burnell 11.)55). Because of the layering effect in flexible containers, serious acute overload can occur if hypertonic additive is not thoroughly mixed (vVilliams Hl7:)). Peripheral infusion of concentrated poi<L';sium usually causes intense local pain, which may identify this mistake promptly in a conscious patient.
In many acute situations, associated alterations . in fluid and acid-base halance, blood sugar and renal function make the effect of any manipulation of potassium difficult to predict. Repeated measurement is therefore essential to achieve any certainty of result.
In almost all potassium-deficient states (except for renal tubular acidosis and ureterosigmoidostomy') there is associated metaholic alkalosis, which makes repair of the potassium deficit almost impossible without chloride repletion. Hence, the importance of KCI ratht'J' than alkaline potassium (Kassirer et al. l!W:i) . In states of fixed mineralocorticoid excess, such as primary aldosteronism, sodiulll restrictioll is the key to achieving potassiulll replacement. The fa(:tor:-;, other than supplements, which are critical in achieving long-term repletion have recently heen re\'iewed (Stockigt 1 H77) .
Chronic potassium deficiency is usually managed hy' long-term oral supplements, but there is no\\' e\'idence that their indiscriminate use i:-; hazardous, especially if there is unrecognized renal impairment (Lawson 1 H7-!).
Plasma potassiulll has been reported to decrease foIlO\\'ing induction of anaesthesia using Thiopentone, ~itrous oxide and Hal()thanc (List IH(7) . This effect is usually small, but serious hypokalaemia occurs during canliopul-ll10nary bqlass. Its mechanism is complcx and has not been fulh' explained, although thc fall in plasrn~t potassium is clearly' tIle result ot internal redistribution rather than urinarv excretion (:\Iarcial et al. J !)()!I). The insuliil response to glucose-containing priming fluids has been suggested as it cause, although \',tlentin and Rasmussen (l!n;i) were unable to confirm this. Other possible causes for hypokalaemia include prior treatment with diuretics, respiratory alkalosis (i\larcial et al. 1969) and most reliable way of correcting hyperkalaemia. Furthermore, the recent studies of Fraley and Adler (1976) indicate that bicarbonate may alter transcellular potassium distribution, irrespective of changes in blood pH and suggest that bicarbonate is useful therapy for hyperkalaemia, even at compensated blood pH. Glucose loads have also been used to rapidly lower plasma potassium, usually with concurrent infusion of insulin, although the latter is dangerous until adrenal insufficiency is ruled out, and is probably unnecessary in non-diabetics. Attempts to restore renal function by repair of volume deficit and treatment of associated sepsis are further urgent priorities.
In some situations, such as extensive muscle damage, plasma potassium may rise at a rate in excess of the capacity for either excretion or redistribution (Grossman et al. 1974) , which should be an indication for urgent dialysis. Successful management of acute hyperkalaemia may be followed by problems of chronic excess, although in some situations there may be underlying depletion.
Most problems of chronic potassium overload relate to severe renal impairment. The kidney has a huge reserve for potassium excretion, so that hyperkalaemia is unusual until over 90% of renal function is lost. Management then involves restriction of dietary protein and potassium, with prevention of sepsis, acidosis and sodium depletion. Inappropriate use of potassium supplements, perhaps with potassiumsparing diuretics such as Spironolactone, Triamterene or Amiloride, remains an important cause of dangerous, remediable hyperkalaemia. Urinary obstruction, pre-renal azotaemia and Addison's disease must also be ruled out. The entity of isolated hypoaldosteronism, due to defective renal renin release (Schambelan, Stockigt and Biglieri 1972) , can present with severe hyperkalaemia, but differs from Addison's disease in showing a normal glucocorticoid response to ACTH. In isolated hypoaldosteronism, long-term management with mineralocorticoid supplement (9 cx=fluorohydrocortisone) is successful in correcting hyperkalaemia, but supplements have little value in treatment of hyperkalaemia due to other causes.
It is well known that abrupt rises in pla~ma potassium may occur following suxamethonium especially in patients with catabolic illness, burns, muscle trauma or spinal cord lesions (Kopriva et al. 1971) . The studies of Bali, Dundee and Doggart (1975) suggest that this is due to muscle trauma during the period of fasiculation and indicate that hyperkalaemia can be avoided by prior curarization.
As in the management of hypokalaemia, frequent biochemical follow-up is essential to monitor the effects of therapy. Each manoeuvre used to manipUlate plasma potassium carries a risk of overshoot which may be worse than the original problem. Furthermore, patients with potassium imbalance rarely have this as their sole abnormality, so that therapy may have to be modified because of associated diseases.
